Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Knudson, Jarrod D ^a   Dincer, Ü Deniz ^a   Dick, Gregory M ^a   Shibata, Haruki ^b   Akahane, Rie ^b   Saito, Masayuki ^c   Tune, Johnathan D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 2 1 1 Shimosueyoshi   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Coronary circulation; Metabolic syndrome; Obesity

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; LEPTIN; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DOG; DOSE RESPONSE; GENE EXPRESSION; HISTOLOGY; HYPERLEPTINEMIA; IMPAIRED GLUCOSE TOLERANCE; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL ANALYSIS;

ADAPTATION, PHYSIOLOGICAL; ANESTHESIA; ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; DIETARY FATS; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIUM, VASCULAR; LEPTIN; MALE; OBESITY; PREDIABETIC STATE; RNA, MESSENGER;

EID: 23944484926     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00244.2005     Document Type: Article

References (53)

1. Bonow RO and Gheorghiade M. The diabetes epidemic: a national and global crisis. Am J Med 116, Suppl 5A: 2S-10S, 2004.
2. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, and Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in dbldb mice. Cell 84: 491-495, 1996.
3. Corsonello A, Perticone F, Malara A, De Domenico D, Loddo S, Buemi M, Ientile R, and Corica F. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 27: 566-573, 2003.
4. Costa LA, Canani LH, Lisboa HR, Tres GS, and Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabei Med 21: 252-255, 2004.
5. Farooqi IS and O'Rahilly S. Monogenic obesity in humans. Annu Rev Med 56: 443-458, 2005.
6. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, and Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1: 1311-1314, 1995.
7. Friedman JM and Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
8. Golden PL, Maccagnan TJ, and Pardridge WM. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 99: 14-18, 1997.
9. Gulick A. A study of weight regulation in the adult human body during over-nutrition. Am J Physiol 60: 371-395, 1922.
10. Guner S, Arioglu E, Tay A, Tasdelen A, Aslamaci S, Bidasee KR, and Dincer UD. Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage. Mol Cell Biochem 263: 143-150, 2004.
11. Iwase M, Kimura K, Komagome R, Sasaki N, Ishioka K, Honjoh T, and Saito M. Sandwich enzyme-linked immunosorbent assay of canine leptin. J Vet Med Sci 62: 207-209, 2000.
12. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D Jr, and Schwartz MW. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol Endocrinol Metab 277;E659-E667, 1999.
13. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 140: 578-596, 1953.
14. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, and Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350: 2549-2557. 2004.
15. Knudson JD, Dincer UD, Zhang C, Swafford AN, Koshida R, Picchi A, Focardi M, Dick GM, and Tune JD. Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 289: H48-H56, 2005. doi:10.1152/ajpheart.01159.2004.
16. Konstantinides S, Schafer K, Koschnick S, and Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108: 1533-1540, 2001.
17. Konstantinides S, Schafer K, and Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann NY Acad Sci 947: 134-141, 2001.
18. Kuo JJ, Jones OB, and Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 37: 670-676, 2001.
19. Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, Aigner F, and Patsch JR. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 26: 659-662, 2002.
20. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, and Stevenson JC. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18: 928-933, 1998.
21. -ΔΔCT method. Methods 25: 402-408, 2001.
22. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, and Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 12: 57-65, 1998.
23. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau J, and Bastard JP. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28: 993-997, 2004.
24. Margetic S, Gazzola C, Pegg GG, and Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26: 1407-1433, 2002.
25. Mark AL, Correia ML, Rahmouni K, and Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20: 1245-1250, 2002.
26. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, and Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52: 2160-2167, 2003.
27. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, and Mantzoros CS. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. ObesRes 11: 1048-1054, 2003.
28. Neumann RO. Experimental contributions to the science of human daily nutritional needs with particular regard to the necessary amount of protein (author's experiments). Arch Hyg Bakteriol 45: 69-78, 1902.
29. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, and Visseren FL. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 25: 342-348, 2004.
30. Parhami F, Tintut Y, Ballard A, Fogelman AM, and Demer LL. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88: 954-960, 2001.
31. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, Muellner C, Speiser W, and Wagner O. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 90: 711-718, 2002.
32. Rahmouni K and Haynes WG. Leptin and the cardiovascular system. Recent Prog Horm Res 59: 225-244, 2004.
33. Rahmouni K, Haynes WG, and Mark AL. Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep 4: 119-125, 2002.
34. Rahmouni K, Haynes WG, Morgan DA, and Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 39: 486-490, 2002.
35. Ren J. Leptin and hyperleptinemia-from friend to foe for cardiovascular function. J Endocrinol 181: 1-10, 2004.
36. Ross R. Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant Proc 25: 2041-2043, 1993.
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
38. Schafer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, and Konstantinides S. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 24: 112-117, 2004.
39. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, and Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
40. Setty S, Sun W, and Tune JD. Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol 98: 416-423, 2003.
41. Shand BI, Scott RS, Elder PA, and George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 5: 349-353, 2003.
42. Shek EW, Brands MW, and Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 31: 409-414, 1998.
43. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, and Olsson T. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246: 409-418, 1999.
44. Soderberg S, Stegmayr B, Ahlbeck-Glader C, Slunga-Birgander L, Ahren B, and Olsson T. High leptin levels are associated with stroke. Cerebrovasc Dis 15: 63-69, 2003.
45. Sweeney G. Leptin signalling. Cell Signal 14: 655-663, 2002.
46. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, and Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs-identification of a missense mutation in Zucker fatty (falfa) rats. Biochem Biophys Res Commun 225: 75-83, 1996.
47. Trayhurn P, Duncan JS, Hoggard N, and Rayner DV. Regulation of leptin production: a dominant role for the sympathetic nervous system? Proc Nutr Soc 57: 413-419, 1998.
48. Wabitsch M. The acquisition of obesity: insights from cellular and genetic research. Proc Nutr Soc 59: 325-330, 2000.
49. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, and Rossetti L. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50: 2786-2791, 2001.
50. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, and Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276: 25096-25100, 2001.
51. Zabeau L, Lavens D, Peelman F, Eyckerman S, Vandekerckhove J, and Tavernier J. The ins and outs of leptin receptor activation. FEBS Lett 546: 45-50, 2003.
52. 1 receptors. Am J Physiol Heart Circ Physiol 288: H2154-H2162, 2005.
53. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, and Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.